Aβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bitan, 2001, Amyloid-beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins, J. Biol. Chem., 276, 35176, 10.1074/jbc.M102223200
Busciglio, 1992, Methodological variables in the assessment of beta amyloid neurotoxicity, Neurobiol. Aging, 13, 609, 10.1016/0197-4580(92)90065-6
Chang, 2001, Nonfibrillar Aβ toxins in AD: an immunoassay to characterize ADDL formation and identify ADDL-blocker compounds, Soc. Neurosci. Abs., 27, 322
Chromy, B.A., Nowak, R., Lambert, M.P., Viola, K.L., Chang, L., Stine, W.B., Priebe, G., Krafft, G.A., Klein, W.L., 2001. Self-assembly of Aβ 1–42 into globular neurotoxins (ADDLs). Biochemistry.
Chui, D.H., Tanahashi, H., Ozawa, K., Ikeda, S., Checler, F., Ueda, O., Suzuki, H., Araki, W., Inoue, H., Shirotani, K., Takahashi, K., Gallyas, F., Tabira, T., 1999. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat. Med. 5, 560–564.
Czech, C., Masters, C., Beyreuther, K., 1994. Alzheimer’s disease and transgenic mice. J. Neural Transm. Suppl. 44, 219–230.
De Ferrari, 2000, Wnt signaling function in Alzheimer’s disease, Brain Res. Brain Res. Rev., 33, 1, 10.1016/S0165-0173(00)00021-7
D’Hooge, R., Nagels, G., Westland, C.E., Mucke, L., De Deyn, P.P., 1996. Spatial learning deficit in mice expressing human 751-amino acid beta-amyloid precursor protein. Neuroreport 7, 2807–2811.
Dodart, J.C., Mathis, C., Bales, K.R., Paul, S.M., Ungerer, A., 2000. Behavioral deficits in APP(V717F) transgenic mice deficient for the apolipoprotein E gene. Neuroreport 11, 603–607.
Gong, 2001, Nonfibrillar Aβ toxins in Alzheimer’s pathogenesis: presence of ADDLs and ADDL-binding proteins in Alzheimer’s disease brains, Soc. for Neurosci. Abs., 27, 322
Hartley, 1999, Protofibrillar intermediates of amyloid-beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons, J. Neurosci., 19, 8876, 10.1523/JNEUROSCI.19-20-08876.1999
Holcomb, L., Gordon, M.N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., Sanders, S., Zehr, C., O’Campo, K., Hardy, J., Prada, C.M., Eckman, C., Younkin, S., Hsiao, K., Duff, K., 1998. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4, 97–100.
Holcomb, L.A., Gordon, M.N., Jantzen, P., Hsiao, K., Duff, K., Morgan, D., 1999. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav. Genet. 29, 177–185.
Hsia, A.Y., Masliah, E., McConlogue, L., Yu, G.Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R.C., Nicoll, R.A., Mucke, L., 1999. Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models. Proc. Natl. Acad. Sci. U.S.A. 96, 3228–3233.
Klein, W.L., 2000. Aβ toxicity in Alzheimer’s Disease. In: Chesselet, M.F., (Ed.), Contemporary Clinical Neuroscience: Molecular Mechanisms of Neurodegenerative Diseases. Humana Press, Totowa, pp. 1–47.
Klein, 2001, Targeting small Abeta oligomers: the solution to an Alzheimer’s disease conundrum?, Trends Neurosci., 24, 219, 10.1016/S0166-2236(00)01749-5
Kumar-Singh, S., Dewachter, I., Moechars, D., Lubke, U., De Jonghe, C., Ceuterick, C., Checler, F., Naidu, A., Cordell, B., Cras, P., Van Broeckhoven, C., Van Leuven, F., 2000. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol. Dis. 7, 9–22.
Lambert, 1998, Diffusible, nonfibrillar ligands derived from Abeta 1–42 are potent central nervous system neurotoxins, Proc. Natl. Acad. Sci. U.S.A., 95, 6448, 10.1073/pnas.95.11.6448
Lambert, 1994, Beta/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells, J. Neurosci. Res., 39, 377, 10.1002/jnr.490390404
Lambert, 2001, Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies, J. Neurochem., 79, 595, 10.1046/j.1471-4159.2001.00592.x
Lansbury, 1997, Structural neurology: are seeds at the root of neuronal degeneration?, Neuron, 19, 1151, 10.1016/S0896-6273(00)80406-7
Larson, J., Lynch, G., Games, D., Seubert, P., 1999. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840, 23–35.
Lesort, 1999, Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and fyn tyrosine kinase, J. Neurochem., 72, 576, 10.1046/j.1471-4159.1999.0720576.x
Liu, 1997, Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis, J. Neurochem., 69, 2285, 10.1046/j.1471-4159.1997.69062285.x
Longo, 2000, Reversible inactivation of superoxide-sensitive aconitase in Aß 1–42-treated neuronal cell lines, J. Neurochem., 75, 1977, 10.1046/j.1471-4159.2000.0751977.x
Loo, 1993, Apoptosis is induced by beta-amyloid in cultured central nervous system neurons, Proc. Natl. Acad. Sci. U.S.A., 90, 7951, 10.1073/pnas.90.17.7951
Lorenzo, 1994, Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red, Proc. Natl. Acad. Sci. U.S.A., 91, 12243, 10.1073/pnas.91.25.12243
Lue, 1999, Soluble amyloid-beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease, Am. J. Pathol., 155, 853, 10.1016/S0002-9440(10)65184-X
Mattson, 1999, Apoptotic biochemical cascades in synaptic compartments: roles in adaptive plasticity and neurodegenerative disorders, J. Neurosci. Res., 58, 152, 10.1002/(SICI)1097-4547(19991001)58:1<152::AID-JNR15>3.0.CO;2-V
McEachern, 1999, The plasticity-pathology continuum: defining a role for the LTP phenomenon, J. Neurosci. Res., 58, 42, 10.1002/(SICI)1097-4547(19991001)58:1<42::AID-JNR6>3.0.CO;2-L
Morgan, 2000, Abeta peptide vaccination prevents memory loss in an animal model of Alzheimer’s disease, Nature, 408, 982, 10.1038/35050116
Mucke, 2000, High-level neuronal expression of Abeta 1–42 in wild-type human amyloid protein precursor transgenic-mice: synaptotoxicity without plaque formation, J. Neurosci., 20, 4050, 10.1523/JNEUROSCI.20-11-04050.2000
Oda, 1994, Purification and characterization of brain clusterin, Biochem. Biophys. Res. Commun., 204, 1131, 10.1006/bbrc.1994.2580
Oda, 1995, Clusterin (Apoj) alters the aggregation of amyloid-beta-peptide (Abeta 1–42) and forms slowly sedimenting Abeta complexes that cause oxidative stress, Exp. Neurol., 136, 22, 10.1006/exnr.1995.1080
Pedersen, W.A. Culmsee, C., Ziegler, D., Herman, J.P., Mattson, M.P., 1999. Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer’s disease. J. Mol. Neurosci. 13, 159–165.
Pike, 1993, Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci., 13, 1676, 10.1523/JNEUROSCI.13-04-01676.1993
Schenk, 1999, Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse, Nature, 400, 173, 10.1038/22124
Shirazi, 1993, The protein tyrosine kinase, fyn, in Alzheimer’s disease pathology, Neuroreport, 4, 435, 10.1097/00001756-199304000-00024
Steward, 2001, Protein synthesis at synaptic sites on dendrites, Annu. Rev. Neurosci., 24, 299, 10.1146/annurev.neuro.24.1.299
Stine, 1996, The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy, J. Protein Chem., 15, 193, 10.1007/BF01887400
Terry, R.D., 1999. The neuropathology of Alzheimer disease and the structural basis of its cognitive alterations. In: Terry, R.D., Katzman, R., Bick, K.L., Sisodia, S.S. (Eds.), Alzheimer Disease. Lippincott Williams, and Wilkins, Philadelphia, PA, pp. 187–206.
Walsh, 1999, Amyloid-beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates, J. Biol. Chem., 274, 25945, 10.1074/jbc.274.36.25945
Walsh, 1997, Amyloid-beta-protein fibrillogenesis: detection of a protofibrillar intermediate, J. Biol. Chem., 272, 22364, 10.1074/jbc.272.35.22364
Wang, H.-W., Pasternak, J.F., Kuo, H., Ristic, H., Lambert, M.P., Chromy, B., Viola, K.L., Klein, W.L., Stine, B., Krafft, G.A., Trommer, B.L., 2001. Soluble oligomers of β amyloid (1–42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res.
Yamaguchi, F., Richards, S.J., Beyreuther, K., Salbaum, M., Carlson, G.A. Dunnett, S.B., 1991. Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. Neuroreport 2, 781–784.
Yao, 2001, The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands, Brain Res., 889, 181, 10.1016/S0006-8993(00)03131-0
Younkin, 1998, The role of Abeta 42 in Alzheimer’s disease, J. Physiol Paris, 92, 289, 10.1016/S0928-4257(98)80035-1
Yuste, 2001, Morphological changes in dendritic spines associated with long-term synaptic plasticity, Annu. Rev. Neurosci., 24, 1071, 10.1146/annurev.neuro.24.1.1071